Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
20393-5 Sample hemolyzed PrThr Ser/Plas Pt Ord     ACTIVE Sample hemolyzed [Presence] of Serum or Plasma Qualitative   MIN DefinitionDescription                   SPEC   20393-5         Observation       0 Sample Hemolyzed SerPl Ql           Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEC; SR 2.73 1.0m                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
20394-3 Sample lipemic PrThr Ser/Plas Pt Ord     ACTIVE Sample lipemic [Presence] of Serum or Plasma Qualitative   MIN DefinitionDescription                   SPEC   20394-3         Observation       0 Sample Lipemic SerPl Ql           Milky; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEC; SR 2.73 1.0m                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
20395-0 Sample integrity Type Ser/Plas Pt Nom     ACTIVE Sample integrity [Type] of Serum or Plasma   MIN DefinitionDescription       Icteric;Hemolyzed;Lipemic           SPEC   20395-0         Observation       0 Sample Integrity SerPl           Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEC; SR; Typ 2.73 1.0m                       0
20396-8 levoFLOXacin Susc Isolate Pt OrdQn MIC   ACTIVE levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   20396-8   MIC     Observation       0 levoFLOXacin Islt MIC           ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 1.0m                       0
20397-6 Sparfloxacin Susc Isolate Pt OrdQn MIC   ACTIVE Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   20397-6   MIC     Observation       0 Sparfloxacin Islt MIC           ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zagam 2.19 1.0m                       0
20398-4 Nuclear Ab pattern.homogeneous Titr Ser Pt SemiQn     ACTIVE Homogenous nuclear Ab pattern [Titer] in Serum   MAJ DefinitionDescription     titer             SERO   20398-4         Both       0 ANA Homogen Titr Ser       Y   ANA; ANA Homogen; ANA Pat; ANF; Antinuclear antibody; Dilution factor; Dilution Factor (Titer); Homogen; NA; Nuc; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1.0m               {titer}       0
20399-2 Nuclear Ab pattern.nucleolar Titr Ser Pt SemiQn     ACTIVE Nucleolar nuclear Ab pattern [Titer] in Serum   MAJ DefinitionDescription     titer             SERO   20399-2         Both       0 ANA nucleolar Titr Ser       Y   ANA; ANA nucleolar; ANA Pat; ANF; Antinuclear antibody; Dilution factor; Dilution Factor (Titer); NA; Nuc; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1.0m               {titer}       0
204-8 Colistin Susc Isolate Pt Qn MLC   ACTIVE Colistin [Susceptibility] by Minimum lethal concentration (MLC)   MIN DefinitionDescription                   ABXBACT   204-8   MLC     Observation       0 Colistin Islt MLC       Y   ANTIBIOTIC SUSCEPTIBILITIES; AST; Colmycin; Colymycin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1                       0
2040-4 Cardiolipin MCnc Ser Pt Qn     ACTIVE Cardiolipin [Mass/volume] in Serum   MIN DefinitionDescription                   COAG   2040-4         Both       0 Cardiolipin Ser-mCnc       Y   Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; COAGULATION; Hematology; Heme; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.34 1                       0
20400-8 Nuclear Ab pattern.smooth nuclear envelope Titr Ser Pt SemiQn     ACTIVE Smooth nuclear envelope nuclear Ab pattern [Titer] in Serum   MAJ DefinitionDescription     titer             SERO   20400-8         Both       0 ANA smooth nucl env Titr Ser       Y   ANA; ANA Pat; ANA smooth nucl env; ANF; Antinuclear antibody; Dilution factor; Dilution Factor (Titer); Membranous; NA; Nuc; Nuclear membrane; Nuclear rim; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1.0m               {titer}     Release 2.70: COMPONENT: Updated "rim" in Component to "smooth nuclear envelope" to align with current nomenclature (https://www.anapatterns.org/view_pattern.php?pattern=11); 0
20401-6 Nuclear Ab pattern.speckled Titr Ser Pt SemiQn     ACTIVE Speckled nuclear Ab pattern [Titer] in Serum   MAJ DefinitionDescription     titer             SERO   20401-6         Both       0 ANA Speckled Titr Ser       Y   ANA; ANA Pat; ANA Speckled; ANF; Antinuclear antibody; Dilution factor; Dilution Factor (Titer); NA; Nuc; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1.0m               {titer}       0
20402-4 Cells.CD16+CD56+ NCnc Bld Pt Qn     ACTIVE CD16+CD56+ cells [#/volume] in Blood   MIN DefinitionDescription     /uL             CELLMARK   20402-4         Both       0 CD16+CD56+ Cells # Bld       Y   #; ABS; absolute; absolutes; Blood; CD16 Cells; CD16+CD56+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; FCGR3A; Leu11; Leu-11; Leu11b; Leu-11B; Leu19; Leu-19; NCAM; Neural cell adhesion molecule; NKH1; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.73 1.0m               /uL       0
20403-2 Fibronectin.fetal MCnc Vag Pt Qn     ACTIVE Fibronectin.fetal [Mass/volume] in Vaginal fluid   MIN DefinitionDescription     ng/mL             CHEM   20403-2         Both       0 Fibronectin Fetal Vag-mCnc       Y   Chemistry; fFN; Fibronectin Fetal; Fn; Genital vaginal; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vag fld; Vag fluid; Vagina; Vaginal fluid 2.73 1.0m               ng/mL       0
20404-0 Fibronectin.fetal PrThr Vag Pt Ord     ACTIVE Fibronectin.fetal [Presence] in Vaginal fluid   MIN DefinitionDescription                   CHEM   20404-0         Both       0 Fibronectin Fetal Vag Ql           Chemistry; fFN; Fibronectin Fetal; Fn; Genital vaginal; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UniversalLabOrders; Vag fld; Vag fluid; Vagina; Vaginal fluid 2.73 1.0m                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
20405-7 Urobilinogen MCnc Urine Pt SemiQn Test strip   ACTIVE Urobilinogen [Mass/volume] in Urine by Test strip   MAJ DefinitionDescription     mg/dL             UA   20405-7   Test strip     Both       0 Urobilinogen Ur Strip-mCnc       Y   Dip stick; Dipstick; Level; Mass concentration; Point in time; Random; SmQn; UA; UBG; UniversalLabOrders; UR; URINALYSIS; Urn; Urobili; Urobilngn 2.75 1.0m               mg/dL       0
20406-5 Glucose MFr Urine Pt Qn Test strip   DEPRECATED Deprecated Glucose [Mass/volume] in Urine by Test strip   MIN DefinitionDescription     % .10%;.25%;.5%;1%;2%           UA   20406-5   Test strip     Both       0 Deprecated Glucose Fr Ur Strip       Y   Dip stick; Dipstick; Glu; Gluc; Glucoseur; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn 2.7 1.0m       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
20407-3 Nitrite MCnc Urine Pt SemiQn Test strip   ACTIVE Nitrite [Mass/volume] in Urine by Test strip   MAJ DefinitionDescription     mg/dL             UA   20407-3   Test strip     Observation       0 Nitrite Ur Strip-mCnc       Y   Dip stick; Dipstick; Level; Mass concentration; NO2; Point in time; Random; SmQn; UA; UR; URINALYSIS; Urn 2.75 1.0m               mg/dL       0
20408-1 Leukocytes NCnc Urine Pt SemiQn Test strip   ACTIVE Leukocytes [#/volume] in Urine by Test strip   MAJ DefinitionDescription     Leu/uL; WBCS/uL Neg;25;50;100;500           UA   20408-1   Test strip     Observation       0 WBC # Ur Strip       Y   #; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Dip stick; Dipstick; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; Random; SmQn; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells 2.75 1.0m               /uL       0
20409-9 Erythrocytes NCnc Urine Pt SemiQn Test strip   ACTIVE Erythrocytes [#/volume] in Urine by Test strip   MAJ DefinitionDescription     ERY/uL; RBCS/uL             UA   20409-9   Test strip     Observation       0 RBC # Ur Strip       Y   #; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Dip stick; Dipstick; Discocytes; Erthrocyte; Erythrocyte; Number concentration; Number Concentration (count/vol); Point in time; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; SmQn; UA; UR; URINALYSIS; Urn 2.75 1.0m               /uL       0
2041-2 Carnitine acyltransferase CCnc Ser/Plas Pt Qn     ACTIVE Carnitine acyltransferase [Enzymatic activity/volume] in Serum or Plasma   MIN DefinitionDescription     arb U/L             CHEM   2041-2         Both       0 Carnitine AcT SerPl-cCnc       Y   Carnitine AcT; Carnitine acyl transferase; Carnitine palmitoyl transerase; Carnitine palmitoyltranserase; Carnitine.total; Catalytic Concentration; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.68 1               U/L       0
20410-7 Amphetamines MCnc Urine Pt Qn Confirm   ACTIVE Amphetamines [Mass/volume] in Urine by Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   20410-7   Confirm     Both       0 Amphetamines Ur Cfm-mCnc       Y   Addiction; Amph; Amphetam; Amphetamine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Speed; UA; UR; Urn 2.73 1.0m               ng/mL       0
20411-5 Barbiturates MCnc Urine Pt Qn Confirm   ACTIVE Barbiturates [Mass/volume] in Urine by Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   20411-5   Confirm     Both       0 Barbiturates Ur Cfm-mCnc       Y   Addiction; Barb; Barbiturate; Barbs; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1.0m               ng/mL       0
20412-3 Benzodiazepines MCnc Urine Pt Qn Confirm   ACTIVE Benzodiazepines [Mass/volume] in Urine by Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   20412-3   Confirm     Both       0 Benzodiaz Ur Cfm-mCnc       Y   Benz; Benzodiaz; Benzodiazepine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1.0m               ng/mL       0
20413-1 Cannabinoids MCnc Urine Pt Qn Confirm   ACTIVE Cannabinoids [Mass/volume] in Urine by Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   20413-1   Confirm     Both       0 Cannabinoids Ur Cfm-mCnc       Y   Addiction; Cannabinoid; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Marijuana; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; THC; UA; UR; Urn 2.73 1.0m               ng/mL       0
20414-9 Thiazides MCnc Urine Pt Qn Confirm   ACTIVE Thiazides [Mass/volume] in Urine by Confirmatory method   MIN DefinitionDescription     mg/L             DRUG/TOX   20414-9   Confirm     Both       0 Thiazides Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.42 1.0m               ng/L       0
104,672 results found